Seizures associated with quetiapine treatment

Annals of Pharmacotherapy

Volumn 37, Issue 9, 2003, Pages 1224-1227

  Dogu, Okan ^a   Sevim, Serhan ^a   Kaleagasi, Hakan S ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Alzheimer disease; Quetiapine; Seizure

Indexed keywords

CARBAMAZEPINE; QUETIAPINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; DISEASE PREDISPOSITION; DRUG MEGADOSE; DRUG MONITORING; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE;

AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; MALE; PSYCHOTIC DISORDERS; SEIZURES;

EID: 0042424762     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C516     Document Type: Article

References (24)

1. Scharre DW, Chang SI. Cognitive and behavioral effects of quetiapine in Alzheimer's disease patients. Alzheimer Dis Assoc Disord 2002;16:128-30.
2. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology 1991;41:369-71.
3. Lee JW, Crismon ML, Dorson PG. Seizure associated with olanzapine. Ann Pharmacother 1999;33:554-6.
4. Simpson GM, Cooper TA. Clozapine plasma levels and convulsions. Am J Psychiatry 1978;135:99-100.
5. Woolley J, Smith S. Lowered seizure threshold on olanzapine. Br J Psychiatry 2001;17:85-6.
6. Hedges DW, Jeppson KG. New-onset seizure associated with quetiapine and olanzapine. Ann Pharmacother 2002;36:437-9. DOI 10.1345/aph. I A207
7. Martin A, Koenig K, Scahill L, Bregman J. Open-label quetiapine in the treatment of children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 1999;9:99-107.
8. Ripple MG, Pestaner JP, Levine BS, Smialek JE. Lethal combination of tramadol and multiple drugs affecting serotonin. Am J Forensic Med Pathol 2000;21:370-4.
9. McKhann G, Drachmann DA, Folstein MF, Katzman R, Price DL, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
11. Kasper S, Muller-Spahn F. Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother 2000;1:783-801.
12. Green B. Focus on quetiapine. Curr Med Res Opin 1999;15:145-51.
13. Beasley CM Jr, Tollefson GD, Tran PV, Satterlee W, Sanger T, Hamilton S. Olanzapine vs. placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996;14:111-23.
14. Wyderski RJ, Starrett WG, Abou-Saif A. Fatal status epilepticus associated with olanzapine therapy. Ann Pharmacother 1999;33:787-9.
15. Dev V, Raniwalla J. Quetiapine. A review of its safety in the management of schizophrenia. Drug Safety 2000;23:295-307.
16. Fitzgerald BJ, Okos AJ. Elevation of carbamazepine-10,11-epoxide by quetiapine. Pharmacotherapy 2002;22:1500-3.
17. Wong YWJ, Yeh C, Thyrum PT. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. J Clin Psychopharmacol 2001;51:189-93.
18. - current in rat dorsal root ganglion neurons: differences between some neuroleptics. Br J Pharmacol 2002;135:1547-55.
19. Emerson RG, Pedley TA. Clinical neurophysiology. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in clinical practice. Vol. 1. 3rd ed. Boston: Butterwort-Heinemann Publishers. 1999:473-96.
20. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology 1996;46:727-30.
21. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990;34:453-68.
22. Arvanitis LA, Miller BG, the Seroquel Trial 13 Study Group. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-46.
23. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 1997;54:549-57.
24. Arvanitis L, Schneider L, Sweitzer D, Young P. "Seroquel" (quetiapine fumarate) may reduce hostility in patients with psychosis related to Alzheimer's disease. Neurology 1999;52(suppl 2):A398-9.